The 15 winners of the FutureHealth Lausanne 2025 Innovation Challenge – selected by the FutureHealth Ecosystem – have been unveiled….

Oculis Holding AG, a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs,…

A shared perspective on two podcast episodes at the heart of Geneva’s scientific life.     How can academic research,…

A groundbreaking study led by the SIB Statistical Genetics Group (University of Lausanne and Unisanté) reveals that the same genetic…

A major discovery in neuroscience: a study from the Faculty of Medicine (FacMed) and the Synapsy Center at the University…

Indian company Aquagri, its partner, and Novochizol SA, a Valais-based startup, announced the launch of AgrINovo, a transformative collaborative project….

Three innovative biotech companies based in Western Switzerland, Stalicla, Legacy Healthcare and iOnctura, have recently achieved significant progress in their…

The merger must take the form of an exchange of all NeuroX shares for newly issued shares in Relief. The…

Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf…

Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by…

Geneva-based biomanufacturing platform planetary is making significant strides in the alternative protein sector through a combination of strategic acquisitions, IP…

Prof. Pedro Herrera and Prof. Giuseppe Iacobucci both receive €150,000 in funding from the European Research Council (ERC)   The…